Cited by 1,518Neuroscience and Neuropharmacology ResearchAmino Acid Enzymes and MetabolismNeuroprotection in Cerebral Ischemia

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Rothstein, Jeffrey D., Patel, Sarjubhai, Regan, Melissa R., Haenggeli, Christine, Huang, Yanhua H., Bergles, Dwight E., Jin, Lin, Dykes Hoberg, Margaret, Vidensky, Svetlana, Chung, Dorothy S., Toan, Shuy Vang, Bruijn, Lucie I., Su, Zao-zhong, Gupta, Pankaj, Fisher, Paul B.·2005·Nature

DOI 10.1038/nature03180

Open this paper in CoChat — free account

Abstract

Glutamate is the principal excitatory neurotransmitter in the nervous system. Inactivation of synaptic glutamate is handled by the glutamate transporter GLT1 (also known as EAAT2; refs 1, 2), the physiologically dominant astroglial protein. In spite of its critical importance in normal and abnormal synaptic activity, no practical pharmaceutical can positively modulate this protein. Animal studies show that the protein is important for normal excitatory synaptic transmission, while its dysfunction is implicated in acute and chronic neurological disorders, including amyotrophic lateral sclerosis (ALS), stroke, brain tumours and epilepsy. Using a blinded screen of 1,040 FDA-approved drugs and nutritionals, we discovered that many beta-lactam antibiotics are potent stimulators of GLT1 expression. Furthermore, this action appears to be mediated through increased transcription of the GLT1 gene. beta-Lactams and various semi-synthetic derivatives are potent antibiotics that act to inhibit bacterial synthetic pathways. When delivered to animals, the beta-lactam ceftriaxone increased both brain expression of GLT1 and its biochemical and functional activity. Glutamate transporters are important in preventing glutamate neurotoxicity. Ceftriaxone was neuroprotective in vitro when used in models of ischaemic injury and motor neuron degeneration, both based in part on glutamate toxicity. When used in an animal model of the fatal disease ALS, the drug delayed loss of neurons and muscle strength, and increased mouse survival. Thus these studies provide a class of potential neurotherapeutics that act to modulate the expression of glutamate neurotransmitter transporters via gene activation.

Integrity signals

Registry

Crossref · 10.1038/nature03180

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Goodman & Gilman's The Pharmacological Basis of Therapeutics
Brunton, L. L. (1985) · Cited by 7,321
Goodman and Gilman's the Pharmacological Basis of Therapeutics
Stigelman, W. H., & Pharm, D. (1986) · Military Medicine · doi:10.1093/milmed/151.1.386 · Cited by 6,796
Glutamate uptake
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Self-citation
Epilepsy and Exacerbation of Brain Injury in Mice Lacking the Glutamate Transporter GLT-1
Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., et al. (1997) · Science · doi:10.1126/science.276.5319.1699 · Cited by 1,755
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Self-citation
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
Rothstein, J. D., Martin, L. J., & Kuncl, R. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205283262204 · Cited by 1,197
Self-citation
Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS)
Howland, D., Liu, J., She, Y., Goad, B., Maragakis, N. J., Kim, B. B., Erickson, J., Kulik, J., DeVito, L., Psaltis, G. C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032539299 · Cited by 890
Self-citation
Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model
Kaspar, B. K., Lladó, J., Sherkat, N., Rothstein, J. D., & Gage, F. H. (2003) · Science · doi:10.1126/science.1086137 · Cited by 872
Self-citation
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes‐Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Self-citation

Flagged first, then by citations

Show all 27 references

Sorted by citations

Items 501–600 of 1,000

Amino Acid Transporters as Disease Modifiers and Drug Targets
Bröer, S. (2018) · SLAS DISCOVERY · doi:10.1177/2472555218755629 · Cited by 53
Treating Neurodegenerative Diseases with Antibiotics
Miller, T. M., & Cleveland, D. W. (2005) · Science · doi:10.1126/science.1109027 · Cited by 52
Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)
Poppe, L., Rué, L., Robberecht, W., & Bosch, L. V. D. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.07.001 · Cited by 54
Emerging drugs for amyotrophic lateral sclerosis
Habib, A. A., & Mitsumoto, H. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.604312 · Cited by 52
Cefdinir for Recent-Onset Pediatric Neuropsychiatric Disorders: A Pilot Randomized Trial
Murphy, T. K., Parker-Athill, E. C., Lewin, A. B., Storch, E. A., & Mutch, P. J. (2014) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2014.0010 · Cited by 52
RIFAMPICIN: An antibiotic with brain protective function
Yuluğ, B., Hanoğlu, L., Kılıç, E., & Schabitz, W. R. (2014) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2014.05.007 · Cited by 51
Establishment and characterization of a new conditionally immortalized human astrocyte cell line
Furihata, T., Ito, R., Kamiichi, A., Saito, K., & Chiba, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13358 · Cited by 51
Drug screening to identify suppressors of GFAP expression
Cho, W., Brenner, M., Peters, N. R., & Messing, A. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq227 · Cited by 53
Current Therapy of Drugs in Amyotrophic Lateral Sclerosis
Lu, H., Le, W. D., Xie, Y.-Y., & Wang, X.-P. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160120152423 · Cited by 51
Beta Lactams Antibiotic Ceftriaxone Modulates Seizures, Oxidative Stress and Connexin 43 Expression in Hippocampus of Pentylenetetrazole Kindled Rats
Hussein, A. M., Ghalwash, M., Magdy, K., & Abulseoud, O. A. (2016) · Journal of Epilepsy Research · doi:10.14581/jer.16002 · Cited by 51
Managing amyotrophic lateral sclerosis: Slowing disease progression and improving patient quality of life
Brooks, B. R. (2009) · Annals of Neurology · doi:10.1002/ana.21544 · Cited by 51
An expert opinion on PANDAS/PANS: highlights and controversies
Chiarello, F., Spitoni, S., Hollander, E., Matucci Cerinic, M., & Pallanti, S. (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1285941 · Cited by 50
CDC Guidelines for the Prevention and Treatment of Anthrax, 2023
Bower, W. A., Yu, Y., Person, M. K., Parker, C. M., Kennedy, J. L., Sue, D., Hesse, E. M., Cook, R., Bradley, J. S., Bulitta, J. B., et al. (2023) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr7206a1 · Cited by 50
Amoxicillin and amoxicillin/clavulanate reduce ethanol intake and increase GLT-1 expression as well as AKT phosphorylation in mesocorticolimbic regions
Goodwani, S., Rao, S., Bell, R. L., & Sari, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.07.008 · Cited by 50
Astrocytes in amyotrophic lateral sclerosis: direct effects on motor neuron survival
Staats, K. A., & Bosch, L. V. D. (2009) · Journal of Biological Physics · doi:10.1007/s10867-009-9141-4 · Cited by 52
Effects of Ceftriaxone on Chronic Ethanol Consumption: a Potential Role for xCT and GLT1 Modulation of Glutamate Levels in Male P Rats
Rao, S., & Sari, Y. (2014) · Journal of Molecular Neuroscience · doi:10.1007/s12031-014-0251-5 · Cited by 50
Physiological and Toxicological Effects of Cefuroxime on the Albino Rabbit Retina
Shahar, J., Zemel, E., Perlman, I., & Loewenstein, A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8053 · Cited by 50
Finding Promiscuous Old Drugs for New Uses
Ekins, S., & Williams, A. J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0486-6 · Cited by 50
Antibiotics as Anti-Inflammatory and Immunomodulatory Agents
Rubin, B. K., & Tamaoki, J. (2005) · Birkhäuser-Verlag eBooks · doi:10.1007/b137084 · Cited by 50
Neuroprotective properties of the excitatory amino acid carrier 1 (EAAC1)
Aoyama, K., & Nakaki, T. (2013) · Amino Acids · doi:10.1007/s00726-013-1481-5 · Cited by 50
Regulation of glutamate transporter 1 (GLT-1) gene expression by cocaine self-administration and withdrawal
Kim, R., Sepulveda-Orengo, M. T., Healey, K. L., Williams, E. A., & Reissner, K. J. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.019 · Cited by 53
Novel Positive Allosteric Modulators of Glutamate Transport Have Neuroprotective Properties in an in Vitro Excitotoxic Model
Falcucci, R. M., Wertz, R., Green, J. L., Meucci, O., Salvino, J. M., & Fontana, A. C. K. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00061 · Cited by 52
Cortical hyperexcitability: Diagnostic and pathogenic biomarker of ALS
Vucic, S., Pavey, N., Haidar, M., Turner, B. J., & Kiernan, M. C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136039 · Cited by 52
Antibiotic Use and Risk of Multiple Sclerosis
Alonso, Á., Jick, S. S., Jick, H., & Hernán, M. Á. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj123 · Cited by 50
GLT1 overexpression in SOD1G93A mouse cervical spinal cord does not preserve diaphragm function or extend disease
Li, K., Hala, T. J., Seetharam, S., Poulsen, D. J., Wright, M. C., & Lepore, A. C. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.03.010 · Cited by 48
Delayed post-ischemic administration of CDP-choline increases EAAT2 association to lipid rafts and affords neuroprotection in experimental stroke
Hurtado, O., Pradillo, J. M., Fernández‐López, D., Morales, J. R., Sobrino, T., Castillo, J., Alborch, E., Moro, M. Á., & Lizasoaín, I. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.08.004 · Cited by 49
Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis
Milanese, M., Giribaldi, F., Melone, M., Bonifacino, T., Musante, I., Carminati, E., Rossi, P. I. A., Vergani, L., Voci, A., Conti, F., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.11.006 · Cited by 50
Efficient tetracycline adsorption and photocatalytic degradation of rhodamine B by uranyl coordination polymer
Ren, Y.-N., Xu, W., Zhou, L.-X., & Zheng, Y. (2017) · Journal of Solid State Chemistry · doi:10.1016/j.jssc.2017.04.005 · Cited by 49
New insights into SMA pathogenesis: immune dysfunction and neuroinflammation
Deguise, M., & Kothary, R. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.423 · Cited by 53
Arundic Acid Increases Expression and Function of Astrocytic Glutamate Transporter EAAT1 Via the ERK, Akt, and NF-κB Pathways
Karki, P., Hong, P., Johnson, J., Pajarillo, E. A. B., Son, D., Aschner, M., & Lee, E.-S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0709-x · Cited by 49
Focal adhesion molecules regulate astrocyte morphology and glutamate transporters to suppress seizure-like behavior
Cho, S., Muthukumar, A. K., Stork, T., Coutinho‐Budd, J., & Freeman, M. R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800830115 · Cited by 50
A circuit-dependent ROS feedback loop mediates glutamate excitotoxicity to sculpt the Drosophila motor system
Peng, J.-J., Lin, S.-H., Liu, Y., Lin, H.-C., Li, T.-N., & Yao, C. (2019) · eLife · doi:10.7554/elife.47372 · Cited by 42
Beneficial Effects of Ceftriaxone Against Pentylenetetrazole-Evoked Convulsions
Jelenković, A., Jovanović, M., Stanimirovic, D. D., Bokonjić, D., Ocic, G. G., & Bošković, B. (2008) · Experimental Biology and Medicine · doi:10.3181/0803-rm-83 · Cited by 49
Bioactive human Alzheimer brain soluble Aβ: pathophysiology and therapeutic opportunities
Li, S., & Stern, A. M. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01589-5 · Cited by 47
Generation of Human iPSC-Derived Astrocytes with a mature star-shaped phenotype for CNS modeling
Voulgaris, D., Nikolakopoulou, P., & Herland, A. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10376-2 · Cited by 46
Antinociceptive evaluation of ceftriaxone and minocycline alone and in combination in a neuropathic pain model in rat
Amin, B., Hajhashemi, V., Hosseinzadeh, H., & Abnous, K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.07.058 · Cited by 48
Crosstalk between astrocytes and motor neurons: What is the message?
Bosch, L. V. D., & Robberecht, W. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.01.008 · Cited by 48
Ceftriaxone Treatment Preserves Cortical Inhibitory Interneuron Function via Transient Salvage of GLT-1 in a Rat Traumatic Brain Injury Model
Hameed, M. Q., Hsieh, T.-H., Morales-Quezada, L., Lee, H. H. C., Damar, U., MacMullin, P., Hensch, T. K., & Rotenberg, A. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy328 · Cited by 48
The Resurrection of Phenotypic Drug Discovery
Childers, W. E., Elokely, K. M., & Abou-Gharbia, M. A. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00006 · Cited by 48
Magnetic resonance spectroscopy of regional brain metabolite markers in FALS mice and the effects of dietary creatine supplementation
Choi, J., Küstermann, E., Dedeoglu, A., & Jenkins, B. G. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.07015.x · Cited by 46
Microglial self-defence mediated through GLT-1 and glutathione
Persson, M., & Rönnbäck, L. (2011) · Amino Acids · doi:10.1007/s00726-011-0865-7 · Cited by 47
Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior
Hammad, A. M., Alasmari, F. F., Althobaiti, Y. S., & Sari, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.06.017 · Cited by 48
Downregulation of the Glial GLT1 Glutamate Transporter and Purkinje Cell Dysfunction in a Mouse Model of Myotonic Dystrophy
Sicot, G., Servais, L., Dincã, D. M., Leroy, A., Prigogine, C., Medja, F., Braz, S. O., Huguet-Lachon, A., Chhuon, C., Nicole, A., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.006 · Cited by 46
EAAT2 density at the astrocyte plasma membrane and Ca2 + -regulated exocytosis
Stenovec, M., Kreft, M., Grilc, S., Pangršič, T., & Zorec, R. (2008) · Molecular Membrane Biology · doi:10.1080/09687680701790925 · Cited by 47
Clavulanic acid: A competitive inhibitor of beta-lactamases with novel anxiolytic-like activity and minimal side effects
Kim, D. J., King, J. A., Zuccarelli, L. A., Ferris, C. F., KOPPEL, G. A., Snowdon, C. T., & Ahn, C. H. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.04.013 · Cited by 47
Predictive methods in drug repurposing: gold mine or just a bigger haystack?
Cavalla, D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.12.009 · Cited by 46
High‐affinity glutamate transporters in chronic pain: an emerging therapeutic target
Gegelashvili, G., & Bjerrum, O. J. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12957 · Cited by 46
Ceftriaxone attenuates hypoxic-ischemic brain injury in neonatal rats
Lai, P., Huang, Y., Wu, C. C., Lai, C.-J., Wang, P. J., & Chiu, T. H. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-69 · Cited by 46
Self-citation
β-Lactam antibiotic produces a sustained reduction in extracellular glutamate in the nucleus accumbens of rats
Rasmussen, B. A., Baron, D. A., Kim, J. K., Unterwald, E. M., & Rawls, S. M. (2010) · Amino Acids · doi:10.1007/s00726-010-0589-0 · Cited by 46
Drug Repurposing for the Development of Novel Analgesics
Sisignano, M., Parnham, M. J., & Geißlinger, G. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.11.006 · Cited by 47
N-Acetylcysteine and Ceftriaxone as Preconditioning Strategies in Focal Brain Ischemia: Influence on Glutamate Transporters Expression
Krzyżanowska, W., Pomierny, B., Budziszewska, B., Filip, M., & Pera, J. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9602-z · Cited by 46
Advances in the Development of Disease-Modifying Treatments for Amyotrophic Lateral Sclerosis
Moujalled, D., & White, A. R. (2016) · CNS Drugs · doi:10.1007/s40263-016-0317-8 · Cited by 48
The role of glutamate in neuronal ion homeostasis: A case study of spreading depolarization
Hübel, N., Hosseini-Zare, M. S., Žiburkus, J., & Ullah, G. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005804 · Cited by 45
Pyrrolidine Dithiocarbamate Inhibits Induction of Immunoproteasome and Decreases Survival in a Rat Model of Amyotrophic Lateral Sclerosis
Ahtoniemi, T., Goldsteins, G., Keksa-Goldsteine, V., Malm, T., Kanninen, K. M., Salminen, A., & Koıstınaho, J. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028415 · Cited by 45
Up‐regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington’s disease
Miller, B., Dorner, J. L., Bunner, K. D., Gaither, T. W., Klein, E. L., Barton, S. J., & Rebec, G. V. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07691.x · Cited by 46
The Endocannabinoid System in Amyotrophic Lateral Sclerosis
Bilsland, L. G., & Greensmith, L. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208785740081 · Cited by 45
Genetic Dys-regulation of Astrocytic Glutamate Transporter EAAT2 and its Implications in Neurological Disorders and Manganese Toxicity
Karki, P., Smith, K., Johnson, J., Aschner, M., & Lee, E.-S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1391-2 · Cited by 50
Divergent Reactivity of 2‐Azetidinone‐Tethered Allenols with Electrophilic Reagents: Controlled Ring Expansion versus Spirocyclization
Alcaide, B., Almendros, P., Luna, A., & Torres, M. R. (2010) · Advanced Synthesis & Catalysis · doi:10.1002/adsc.200900864 · Cited by 45
Glutamatergic mechanisms of comorbidity between acute stress and cocaine self-administration
García‐Keller, C., Kupchik, Y. M., Gipson, C. D., Brown, R. M., Spencer, S. M., Bollati, F. A., Esparza, M. A., Roberts-Wolfe, D., Heinsbroek, J. A., Bobadilla, A., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.151 · Cited by 43
Neuroglial alterations in the zebrafish brain exposed to cadmium chloride
Monaco, A., Grimaldi, M. C., & Ferrandino, I. (2016) · Journal of Applied Toxicology · doi:10.1002/jat.3328 · Cited by 45
Astrocyte‐specific deletion of the mitochondrial m‐AAA protease reveals glial contribution to neurodegeneration
Murru, S., Heß, S., Barth, E., Almajan, E.-R., Schatton, D., Hermans, S., Brodesser, S., Langer, T., Kloppenburg, P., & Rugarli, E. I. (2019) · Glia · doi:10.1002/glia.23626 · Cited by 46
Upregulation of GLT-1 via PI3K/Akt Pathway Contributes to Neuroprotection Induced by Dexmedetomidine
Peng, M., Ling, X., Song, R., Gao, X., Liang, Z., Fang, F., & Cang, J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01041 · Cited by 45
Glial Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent Control of Extrasynaptic Dopamine Signaling
Hardaway, J. A., Sturgeon, S. M., Snarrenberg, C. L., Li, Z., Xu, X. Z. S., Bermingham, D. P., Odiase, P., Spencer, W. C., Miller, D. M., Carvelli, L., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0800-15.2015 · Cited by 43
CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes
Catalano, M., Lauro, C., Cipriani, R., Chece, G., Ponzetta, A., Angelantonio, S. D., Ragozzino, D., & Limatola, C. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.07.020 · Cited by 44
Glutamate transporter blockers for elucidation of the function of excitatory neurotransmission systems
Shimamoto, K. (2008) · The Chemical Record · doi:10.1002/tcr.20145 · Cited by 44
Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight
Angoa‐Pérez, M., & Kuhn, D. M. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000144 · Cited by 44
A New Synthetic Approach to Novel Spiro‐β‐lactams
Bhalla, A., Venugopalan, P., & Bari, S. S. (2006) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200600458 · Cited by 44
Insulin-like growth factor 1 in diabetic neuropathy and amyotrophic lateral sclerosis
Rauskolb, S., Dombert, B., & Sendtner, M. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.04.007 · Cited by 45
Role of astrocytic glutamate transporter in alcohol use disorder
Ayers-Ringler, J. R., Jia, Y., Qiu, Y., & Choi, D. (2016) · World Journal of Psychiatry · doi:10.5498/wjp.v6.i1.31 · Cited by 43
In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1 mouse model of amyotrophic lateral sclerosis
Bonifacino, T., Cattaneo, L., Gallia, E., Puliti, A., Melone, M., Provenzano, F., Bossi, S., Musante, I., Usai, C., Conti, F., et al. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.020 · Cited by 42
Higher ambient synaptic glutamate at inhibitory versus excitatory neurons differentially impacts NMDA receptor activity
Yao, L., Grand, T., Hanson, J. E., Paoletti, P., & Zhou, Q. (2018) · Nature Communications · doi:10.1038/s41467-018-06512-7 · Cited by 46
Glutamate transport system as a key constituent of glutamosome: Molecular pathology and pharmacological modulation in chronic pain
Gegelashvili, G., & Bjerrum, O. J. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.029 · Cited by 43
Neuroprotective Interventions Targeting Detrimental Host Immune Responses Protect Mice From Fatal Alphavirus Encephalitis
Irani, D. N., & Prow, N. A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000263867.46070.e2 · Cited by 43
Single Cell Immuno-Laser Microdissection Coupled to Label-Free Proteomics to Reveal the Proteotypes of Human Brain Cells After Ischemia
García‐Berrocoso, T., Llombart, V., Campàs, L. C., Hainard, A., Licker, V., Peñalba, A., Ramiro, L., Simats, A., Bustamante, A., Martínez-Sáez, E. A., et al. (2017) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra117.000419 · Cited by 42
Imaging in Vivo Glutamate Fluctuations with [ 11 C]ABP688: A GLT-1 Challenge with Ceftriaxone
Zimmer, E. R., Parent, M. J., Leuzy, A., Aliaga, A., Aliaga, A., Moquin, L., Schirrmacher, E. S., Soucy, J., Skelin, I., Gratton, A. P., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.35 · Cited by 42
Ceftriaxone, a GLT-1 transporter activator, disrupts hippocampal learning in rats
Matos-Ocasio, F., Hernández, A., & Thompson, K. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.03.011 · Cited by 44
Neuroprotective effects of ceftriaxone treatment on cognitive and neuronal deficits in a rat model of accelerated senescence
Tikhonova, M. A., Ho, S.-C., Akopyan, A. A., Kolosova, N. G., Weng, J., Meng, W.-Y., Lin, C., Amstislavskaya, T. G., & Ho, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.05.002 · Cited by 42
Excessive spinal glutamate transmission is involved in oxaliplatin-induced mechanical allodynia: a possibility for riluzole as a prophylactic drug
Yamamoto, S., Ushio, S., Egashira, N., Kawashiri, T., Mitsuyasu, S., Higuchi, H., Ozawa, N., Masuguchi, K., Ono, Y., & Masuda, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-08891-1 · Cited by 42
Glutamate homeostasis and dopamine signaling: Implications for psychostimulant addiction behavior
Fischer, K. D., Knackstedt, L. A., & Rosenberg, P. A. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104896 · Cited by 42
Targeted gut microbiota manipulation attenuates seizures in a model of infantile spasms syndrome
Mu, C., Nikpoor, N., Tompkins, T. A., Choudhary, A., Wang, M., Marks, W. N., Rho, J. M., Scantlebury, M. H., & Shearer, J. (2022) · JCI Insight · doi:10.1172/jci.insight.158521 · Cited by 43
Immunomodulatory effects of antimicrobial agents. Part I: antibacterial and antiviral agents
Labro, M. T. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.11 · Cited by 41
Glutamate transporter 1-mediated antidepressant-like effect in a rat model of chronic unpredictable stress
Chen, J.-X., Yao, L.-H., Xu, B.-B., Qian, K., Wang, H.-L., Liu, Z.-C., Wang, X.-P., & Wang, G.-H. (2014) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-014-1362-5 · Cited by 39
Molecular docking, molecular dynamics simulations and in vitro screening reveal cefixime and ceftriaxone as GSK3β covalent inhibitors
Nassar, H., Sippl, W., Abu‐Dahab, R., & Taha, M. O. (2023) · RSC Advances · doi:10.1039/d3ra01145c · Cited by 41
δ‐Opioid receptors up‐regulate excitatory amino acid transporters in mouse astrocytes
Liang, J., Chao, D., Sandhu, H. K., Yu, Y., Zhang, L., Balboni, G., Kim, D., & Xia, Y. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12857 · Cited by 41
Beta-lactam antibiotic decreases acquisition of and motivation to respond for cocaine, but not sweet food, in C57Bl/6 mice
Ward, S. J., Rasmussen, B. A., Corley, G., Henry, C., Kim, J. K., Walker, E. A., & Rawls, S. M. (2011) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283473c10 · Cited by 41
Pre-Conditioning Induces the Precocious Differentiation of Neonatal Astrocytes to Enhance Their Neuroprotective Properties
Sen, E., Basu, A., Willing, L. B., Uliasz, T. F., Myrkalo, J., Vannucci, S. J., Hewett, S. J., & Levison, S. W. (2011) · ASN NEURO · doi:10.1042/an20100029 · Cited by 42
Mutation of the caspase-3 cleavage site in the astroglial glutamate transporter EAAT2 delays disease progression and extends lifespan in the SOD1-G93A mouse model of ALS
Rosenblum, L. T., Markandaiah, S. S., Ghosh, B., Foran, E., Lepore, A. C., Pasinelli, P., & Trotti, D. (2017) · Experimental Neurology · doi:10.1016/j.expneurol.2017.03.014 · Cited by 42
The ameliorative effects of ceftriaxone and vitamin E against cisplatin-induced nephrotoxicity
Abdel‐Daim, M. M., Aleya, L., El‐Bialy, B. E., Abushouk, A. I., Alkahtani, S. H., Alarifi, S. A., Alkahtane, A. A., Albasher, G. I., Ali, D., Almeer, R., et al. (2019) · Environmental Science and Pollution Research · doi:10.1007/s11356-019-04801-2 · Cited by 41
Antibiotics: A Bibliometric Analysis of Top 100 Classics
Arshad, A. I., Ahmad, P., Karobari, M. I., Asıf, J. A., Alam, M. K., Mahmood, Z., Rahman, N. A., Mamat, N., & Kamal, M. A. (2020) · Antibiotics · doi:10.3390/antibiotics9050219 · Cited by 42
Neurobiology, Functions, and Relevance of Excitatory Amino Acid Transporters (EAATs) to Treatment of Refractory Epilepsy
Zaitsev, A. V., Smolensky, I. V., Jorratt, P., & Ovsepian, S. V. (2020) · CNS Drugs · doi:10.1007/s40263-020-00764-y · Cited by 41
Regulation of ethanol-sensitive EAAT2 expression through adenosine A1 receptor in astrocytes
Wu, J., Lee, M. R., Kim, T. H., Johng, S., Rohrback, S., Kang, N., & Choi, D. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.01.104 · Cited by 41
β-Lactam antibiotics are multipotent agents to combat neurological diseases
Ji, H., Shen, L., & Zhang, H. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.014 · Cited by 41
Obtaining and screening compound collections: a user's guide and a call to chemists
Hergenrother, P. J. (2006) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2006.04.005 · Cited by 41
Biotic acts of antibiotics
Aminov, R. I. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00241 · Cited by 40
Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis
Morren, J. A., & Gálvez-Jiménez, N. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.657303 · Cited by 40
Ceftriaxone and cefazolin attenuate the cue-primed reinstatement of alcohol-seeking
Weiland, A. K., Garcia, S., & Knackstedt, L. A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00044 · Cited by 40
Neuroprotective Effects of the Glutamate Transporter Activator ( R )-(−)-5-methyl-1-nicotinoyl-2-pyrazoline (MS-153) following Traumatic Brain Injury in the Adult Rat
Fontana, A. C. K., Fox, D. P., Zoubroulis, A., Mortensen, O. V., & Raghupathi, R. (2015) · Journal of Neurotrauma · doi:10.1089/neu.2015.4079 · Cited by 40
Regulated Exocytosis and Vesicle Trafficking in Astrocytes
Kreft, M., Potokar, M., Stenovec, M., Pangršič, T., & Zorec, R. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.04005.x · Cited by 42
Orphan/rare drug discovery through drug repositioning
Muthyala, R. (2011) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2011.10.003 · Cited by 40
The beta‐lactam antibiotic, ceftriaxone, attenuates morphine‐evoked hyperthermia in rats
Rawls, S. M., Tallarida, R. J., Robinson, W., & Amin, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707309 · Cited by 40

Authors: Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., Jin, L., Dykes Hoberg, M., Vidensky, S., Chung, D. S., Toan, S. V., Bruijn, L. I., Su, Z.-Z., Gupta, P., & Fisher, P. B.
Affiliations: Johns Hopkins University (US)
Amyotrophic Lateral Sclerosis Association (US)
Columbia University Irving Medical Center (US)
Corresponding author: Rothstein, Jeffrey D.
ORCID: Rothstein, Jeffrey D.
Huang, Yanhua H.
Bergles, Dwight E.
Gupta, Pankaj
Fisher, Paul B.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2005-01
Volume: 433
Issue: 7021
Pages: 73-77
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature03180
OpenAlex: W2083204774
Cited by: 1,518
References: 27
Citations by year: 2026: 49 · 2025: 52 · 2024: 47 · 2023: 48 · 2022: 53 · 2021: 55 · 2020: 60 · 2019: 56 · 2018: 52 · 2017: 76 · 2016: 85 · 2015: 84 · 2014: 107 · 2013: 96 · 2012: 98
FWCI: 31.20
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Funders: Muscular Dystrophy Association
Johns Hopkins University
Robert Packard Center for ALS Research, Johns Hopkins University
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
Keywords: beta-lactam antibiotics, ceftriaxone, penicillin, GLT-1, glutamate transporters, neuroprotection, glutamate excitotoxicity, amyotrophic lateral sclerosis, ischemic brain injury, motor neuron degeneration, drug repurposing, transcriptional activation, astrocytes
MeSH terms: Animals, Anti-Bacterial Agents, Ceftriaxone, Cell Count, Cells, Cultured, Central Nervous System, Drug Evaluation, Preclinical, Gene Expression Regulation, Mice, Transgenic, Motor Neurons, Penicillins, Promoter Regions, Genetic, RNA, Messenger, United States, United States Food and Drug Administration, Transcriptional Activation, Genes, Reporter, Neuroprotective Agents, Ischemic Preconditioning, Excitatory Amino Acid Transporter 2, beta-Lactams, Mice, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks